Drug Trial Radar · NCT07421232
A Study to Evaluate the Safety, Efficacy of SYH2053 in Chinese Participants With Non-familial Hypercholesterolemia and Mixed Hyperlipidemia
Last checked: Nov 19, 2026Latest source record: Feb 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
156
Actual
Start
Dec 3, 2024
Primary completion
Aug 30, 2025
Study completion Feb 12, 2026
Sponsor
- Lead sponsor
- CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Feb 19, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (participant)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to compare the effectiveness, safety of SYH2053 in Participants with primary hypercholesterolemia or mixed dyslipidemia. A total of 156 Participants were actually enrolled
Conditions
- Hypercholesterolemia and Mixed Hyperlipidemia
Interventions
SYH2053/placebo injectionDrug
Participants receive SYH2053/placebo injection by subcutaneous administration.
Inclisiran (Leqvio®) 300mgDrug
Participants receive Leqvio® injection by subcutaneous administration.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage change in LDL-C relative to baselineTime frame: Day 180
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Affiliation: Peking University Third Hospital
Beijing, Beijing Municipality, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.